Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival by Sze, Daniel M.-Y. et al.
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/09/813/09 $5.00
Volume 192, Number 6, September 18, 2000 813–821
http://www.jem.org/cgi/content/full/192/6/813
 
813
 
Intrinsic Constraint on Plasmablast Growth
and Extrinsic Limits of Plasma Cell Survival
 
By Daniel M.-Y. Sze, Kai-Michael Toellner, Carola García de Vinuesa, 
Dale R. Taylor, and Ian C.M. MacLennan
 
From the University of Birmingham/Medical Research Council Centre for Immune Regulation, 
The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
 
Abstract
 
B cells recruited into splenic antibody responses grow exponentially, either in extrafollicular
foci as plasmablasts, or in follicles where they form germinal centers. Both responses yield
plasma cells. Although many splenic plasma cells survive 
 
,
 
3 d, some live much longer. This
study shows that early plasma cell death relates to a finite capacity of the spleen to sustain
plasma cells rather than a life span endowed by the cell’s origin or the quality of antibody it
produces. Antibody responses were compared where the peak numbers of plasma cells in
spleen sections varied between 100 and 5,000 cells/mm
 
2
 
. In each response, plasmablast clones
divided some five times, with the peak numbers of plasma cells produced relating directly to
the number of B cells recruited into the response. The spleen seems to have the capacity to sus-
tain between 20 and 100 plasma cells/mm
 
2
 
. When this number is exceeded, there is a loss of
excess cells. Immunoglobulin variable region gene sequencing, and 5-bromo-2
 
9
 
-deoxyuridine
pulse–chase studies indicate that long-lived splenic plasma cells are a mixture of cells derived
from the extrafollicular and germinal center responses and cells derived from virgin and mem-
ory B cells. Only a proportion has switched immunoglobulin class.
Key words: plasma cell survival • plasmablast growth • hypermutation • immunoglobulin class 
switch • spleen
 
Introduction
 
B cells activated in the outer T zone in the spleen migrate
either to extrafollicular sites where they grow as plasma-
blasts or to follicles where they form germinal centers (1–
4). The growth of plasmablasts in mouse spleen typically
occurs in extrafollicular foci, located at the junction of the
red pulp with the T zone (2–4). In mice with transgenic B
cells, when exceptional numbers of antigen-specific B cells
are recruited into the extrafollicular response, plasmablast
growth can occur throughout the red pulp (5). Plasmablasts
growing in the extrafollicular response differentiate locally
into plasma cells, and many of these are lost from the spleen
within 2–3 d (6, 7)—many by apoptosis in situ (7). Some
antigen-specific plasma cells are found in the spleen for sev-
eral weeks after immunization (4, 6). The origin, fate, and
life span of these cells are considered in this report.
In this study, information about the origin of persistent
red pulp plasma cells is provided by analysis of their Ig V
region genes. Plasmablasts growing in extrafollicular foci do
not appear to acquire the mutations in their Ig V region
genes that arise in B cells in germinal centers (3). Individual
immunohistologically identified antigen-specific plasma cells
have been picked from the red pulp of tissue sections at dif-
ferent times after immunization. The Ig V regions of these
have been amplified and sequenced, using the principles es-
tablished by Küppers et al. in studies of single cells from
human germinal centers (8). It is shown that a mixture of
mutated and nonmutated splenic plasma cells avoid an early
death.
Plasma cells in the bone marrow play a dominant role in
sustaining systemic antibody production, and many of these
plasma cells are derived from B cells activated in the spleen
(9–12). Ig V region analysis of bone marrow plasma cells in
responses to hapten protein indicates that most, but not all,
have mutations in their Ig V region genes (11, 12). Those
with mutations are likely to come from B cells that have
undergone hypermutation and selection in germinal cen-
ters (13). It is not clear if some or all of the nonmutated
bone marrow plasma cells come from extrafollicular anti-
body responses. Some may be nonmutated B cells emerg-
ing from germinal centers. Despite the dominant role of
the bone marrow in systemic antibody production, recent
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studies have identified a contribution by long-lived splenic
plasma cells to the continued production of virus-neutraliz-
ing antibody (14) and antiovalbumin antibody (15).
Further information about the origin of long-lived plasma
cells in the spleen has been obtained using 5-bromo-2
 
9
 
-deoxy-
uridine (BrdU)
 
1
 
 pulse–chase experiments. BrdU pulses
were given during antibody responses either during ex-
trafollicular plasmablast growth, which ends on the fourth
day after immunization, or in the second or third week of
the response when B cell proliferation only continues in
germinal centers (2, 4). This approach suggests that the
long-lived plasma cells in the spleen are a mixture of cells
produced in follicles and extrafollicular foci; some are de-
rived from activation of virgin B cell and some from mem-
ory cells.
 
Materials and Methods
 
Mice.
 
Specific pathogen-free female B10A and C57BL/6
mice (Harlan) were maintained in isolators within the Animal
Unit of The Birmingham University. Both strains are homozy-
gous for the IgH
 
b
 
 
allotype. Quasimonoclonal (QM) mice were
provided by Marilia Cascalho and Matthias Wabl (University of
California at San Francisco, San Francisco, CA [16]) and were
bred and maintained in our animal unit.
 
Antigens and Immunization Procedures.
 
Mice were immunized
when aged 6–10 wk. The hapten (3-nitro-4-hydroxy-phenyl)
acetyl (NP) was conjugated as its succinimide ester (Cambridge
Research Biochemicals) to chicken gamma globulin (CGG;
Sigma-Aldrich) to give a substitution ratio of 18 NP per CGG as
described previously (17). Alum precipitates were freshly pre-
pared from stock solutions of CGG as described elsewhere (18).
Primary immunization was intraperitoneal using 50 
 
m
 
g alum-pre-
cipitated CGG plus 5 
 
3
 
 10
 
8
 
 chemically killed 
 
Bordetella pertussis
 
(Evans Medical). Secondary immunization (5 wk after priming)
used 50 
 
m
 
g soluble NP-CGG in 200 
 
m
 
l sterile PBS, injected in-
traperitoneally. Cells in S phase were identified by the uptake of
BrdU given as a 2-mg intraperitoneal injection 2 h before tissues
were taken for histology. In longer pulses, a 2-mg intraperitoneal
injection of BrdU was followed by administering BrdU at 1 mg/
ml in the drinking water.
 
Tissue Preparation for Immunohistology.
 
Mice were killed by
CO
 
2 
 
asphyxiation; after taking blood, the spleens were removed
and immediately snap frozen by repeated dipping in liquid N
 
2
 
.
5-
 
m
 
m cryostat sections were prepared and stained as described
previously (4). The following antibodies were used in addition to
those described in reference 4: rat anti–mouse CD3 (17A2; a gift
from H. Acha-Orbea, University of Lausanne, Lausanne, Swit-
zerland), rat anti–mouse syndecan-1 (281-2; BD PharMingen),
and a cocktail of rat anti–mouse mAbs specific for all four IgG
subclasses, IgG1 (LO-MG1-2), IgG2a (LO-MG2A-3), IgG2b
(LO-MG2b-2), and IgG3 (LO-MG3-7) (Serotec Ltd.). Tissue
sections were triple-stained to show the expression of: (a) CD3,
IgD, and BrdU; (b) NP- or CGG-binding antibody, IgD, and
BrdU; (c) NP- or CGG-binding antibody, syndecan-1 (19), and
BrdU; and (d) NP- or CGG-binding antibody, IgG, and BrdU.
The first named molecule in each of these triple stains was re-
 
vealed in blue by immunoalkaline phosphatase, the second mole-
cule as brown precipitate by immunoperoxidase. After this, the
nuclei of cells that had incorporated BrdU were identified in red,
again using immunoalkaline phosphatase, after the sections had
been treated with acid to expose the BrdU-associated epitopes on
DNA.
 
Quantification of NP- and CGG-binding B Cells in Tissue Sec-
tions.
 
The T zones, follicles, and red pulp were located using
triple staining for CD3, IgD, and BrdU. NP-binding cells and
CGG-binding cells were quantified on two adjacent sections, one
stained to show NP-binding cells, the other to show CGG-bind-
ing cells. Together with the antigen-specific cells, the sections
were stained to show IgD expression and BrdU incorporation.
This allowed the location of antigen-specific B cells and plasma
cells, in either the T zone or red pulp, to be identified. The size
of splenic compartments and the number of cells per square milli-
meter of each compartment were determined using a point
counting technique (20). The data are expressed as the numbers
of antigen-specific cells per square millimeter of total section area,
or per square millimeter of splenic compartment.
 
Isolation of Individual Antigen-specific Antibody-containing Cells.
 
Adjacent sections were stained for NP binding with IgD and NP
binding with syndecan-1. Cells were identified by bright field
microscopy. NP-specific plasmablasts and plasma cells can be
readily identified as cells staining strongly for cytoplasmic Ig and
syndecan-1 expression. Staining for IgD expression on adjacent
sections allows the demarcation of the splenic compartments. In-
dividual NP-binding plasma cells in the red pulp were selected at
random. Cells were removed from the stained sections using a
micromanipulator-controlled glass capillary with a fine tip, being
careful not to take material from surrounding antigen-specific
cells.
 
Amplification of V Region Genes from Single Plasma Cells.
 
The
digestion and DNA amplification protocols were adapted from
Jacob et al. (13) with modifications. Material from each cell re-
covered by microdissection was put into a 0.2-ml well of a 96-
well PCR plate containing 25 
 
m
 
l of 0.2
 
3
 
 PBS with 10 
 
m
 
g pro-
teinase K (Boehringer). The plate was incubated at 56
 
8
 
C for 2 h
followed by heat inactivation of the proteinase (10 min, 96
 
8
 
C).
The lysates were then subjected to 2 sets of 40 cycles of PCR
with nested primers as described (13). The first round PCR was
carried out in a 50-
 
m
 
l volume containing 25 
 
m
 
l of the digestion
product, 1
 
3
 
 Pfu buffer (Stratagene), 0.01% gelatin type B from
bovine skin (Sigma-Aldrich), 0.4 mM dNTP (Promega), 0.4 
 
m
 
M
of each primer, and 1.25 U recombinant Pfu polymerase (Strat-
agene). No mineral oil was added; the plates were sealed with ad-
hesive sheets (Hybaid). The reaction was run in a Touch Down
thermal cycler (Hybaid). The second nested PCR used 2 
 
m
 
l of
the reaction mixture from the first PCR.
 
DNA Sequencing.
 
25 
 
m
 
l of secondary PCR products was sub-
jected to agarose gel electrophoresis. The DNA was extracted
from the agarose using a commercial extraction kit (QIAquick
Gel Extraction kit; QIAGEN). The extracted DNA was se-
quenced in both directions using the dye terminator cycle se-
quencing technique (ABI PRISM ready reaction kit; Perkin-
Elmer) using the same primers as for the secondary PCR.
Fluorescent-labeled cycle sequencing product was ethanol pre-
cipitated and read by Alta Biosciences on an ABI 377 machine
(PerkinElmer).
 
Frequency of Pfu-induced Artefactual Mutations.
 
The frequency
of polymerase-induced mutations was determined by sequencing
the rearranged Ig V region gene from single B1-8 cells which
contains an unmutated V186.2 V region segment linked to
 
1
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9
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DFL16.1 and J
 
H
 
2 (21; a gift of G. Kelsoe, Duke University,
Durham, NC). Each cell was recovered from a cytospin prepara-
tion; the digestion and amplification protocols were identical to
those used on splenic sections. No mutation was observed in
6,000 bp sequenced. The measured error rate of the Pfu has been
reported as 1–2 
 
3 
 
10
 
2
 
6
 
 misincorporations/bp/cycle (22). This
low error frequency is sufficient to allow the assumption that vir-
tually all recovered mutations represent
 
 
 
in vivo events, a conclu-
sion supported by the analysis of sequences from 9 NP-specific
plasma cells taken at day 7 of a primary response to NP-CGG and
16 plasma cells taken from day 6 of a primary response to NP-Ficoll.
All of these had nonmutated V segments; CDR3 junctional di-
versity showed them to be from separate clones (23).
 
Results and Discussion
 
The Peak Number of Antibody-producing Cells Generated
during a Splenic Extrafollicular Antibody Response Is Directly
Related to the Number of B Cells Recruited into the Response,
but the Life Span of Plasma Cells Reflects a Finite Capacity of
the Spleen to Sustain Their Survival.
 
The peak numbers of
plasma cells produced in the spleen in different extrafolli-
cular antibody responses vary greatly. To investigate the
factors that account for this variability, a range of immune
responses was analyzed in which the number of antigen-
specific B cells available varied. B cell recruitment into each
response, the peak numbers of antibody-producing cells
generated, and the proportion of these cells that survived
for 
 
.
 
1 wk were determined. The analysis identifies a direct
relationship between the number of B cells recruited into
an antibody response and the peak numbers of plasma cells
produced. It also indicates that the capacity of the spleen to
maintain plasma cells for 
 
.
 
1 wk is finite and unrelated to
the peak number of antibody-producing cells generated.
 
Plasmablast Growth and Plasma Cell Survival When Low
Numbers of B Cells Are Recruited into the Extrafollicular Re-
sponse.
 
The primary responses to intraperitoneal immuni-
zation with alum-precipitated NP-CGG plus killed 
 
B
 
.
 
 pertus-
sis
 
 were used to exemplify the situation in which relatively
low numbers of antigen-specific B cells are available
 
 
 
(3, 4).
In this response, the median peak number of antibody-pro-
ducing cells generated was 112 cells/mm
 
2
 
 of red pulp (Fig.
1). Of these, a median of 88% (range 81–98%) was NP spe-
cific and 12% (range 2–19%) CGG specific. This presum-
ably reflects the relative frequency of virgin B cells of these
two specificities that were recruited into the response. The
peak numbers of NP-specific plasma cells and CGG-spe-
cific plasma cells were both reached on the tenth day after
immunization. After this, there was no significant fall in the
number of antigen-specific plasma cells in the spleen
through day 18. The number of B cells recruited into this
response was too low to determine accurately, and its de-
termination is complicated by the likely continued recruit-
ment of B cells into the response for some days.
 
Plasmablast Growth and Plasma Cell Survival When Interme-
diate Numbers of B Cells Are Recruited into the Extrafollicular
Response.
 
Study of the recruitment of intermediate num-
bers of B cells was carried out in the response to soluble in-
travenous NP-CGG in mice primed 5 wk before with
alum-precipitated CGG plus killed 
 
B
 
.
 
 pertussis
 
 (4). A me-
dian of eight CGG-specific B cells/mm
 
2
 
 of spleen accumu-
lated in the outer T zone by 12 h after immunization, and
this number did not increase significantly by 24 h, reflect-
ing the short period when B cells are recruited into this re-
sponse (Fig. 1). Most of the cells were in S phase of the cell
cycle at 24 h, as assessed by the uptake of BrdU given 2 h
before the spleen was taken. Fewer than 1 NP-specific B
cell/mm
 
2
 
 was seen in the T zone at this stage. After this,
the numbers of antigen-specific cells in the extrafollicular
response increased exponentially to peak at 96 h, when a
median of 413 CGG-specific antibody-containing cells/
mm
 
2
 
 was present. These were mainly found in extrafollicu-
lar foci located at the junction of the T zone and red pulp
(Fig. 2, a and b). By 7 d after immunization, the numbers
of plasma cells had fallen into the range of 10–170 cells/
mm
 
2
 
 and were sustained at this level through 21 d. This
range of plasma cell frequency is similar to that sustained
into the third week of the primary response to NP-CGG
(Fig. 1). By 21 d, the plasma cells were no longer concen-
trated in extrafollicular foci, but were scattered throughout
the red pulp (Fig. 2 c). At the peak of the response, medi-
ans of 80% (range 63–87%) of the antigen-specific plasma
cells were CGG specific and 20% (range 13–37%) were NP
specific (Fig. 2 b and Fig. 3). This is the reverse of the
CGG-specific to NP-specific cell ratio seen in the primary
response to NP-CGG, indicating that almost all of the
Figure 1. Evidence that plasma cells go through a fixed number of cell
cycles irrespective of the number of B cells recruited into extrafollicular
antibody responses, but that the spleen has a finite capacity to sustain
plasma cells produced. The horizontal gray bar indicates the range of sus-
tainable plasma cell numbers. Three examples are given of plasmablast
growth, differentiation, and survival where the starting number of B cells
recruited into the extrafollicular response varies. The number of cells re-
cruited into the response is identified by the number of antigen-specific B
cells found in the outer T zone 12–24 h after immunization. These then
go into exponential growth for 3 d. Diamonds represent values obtained
from individual B10A mice during a primary response to NP-CGG (ref-
erence 4); the dotted line is drawn through median values. The delay in
the onset of plasmablast growth in this response reflects the time taken for
help from primed T cells to become available. Filled circles show values
for a response of CGG-primed B10A mice to NP-CGG (reference 4); the
solid line is drawn through median values for this response. Triangles rep-
resent values for red pulp NP-specific plasma cells obtained during the re-
sponse of QM mice to NP-Ficoll (reference 5). Some 60% of the B cells
these mice have transgenic receptors specific for NP; the dashed line is
drawn through median values of this response. 
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CGG-specific cells recruited into the response in carrier-
primed mice were memory B cells.
Detailed analysis of the transition from plasmablasts,
which are in cell cycle and label with BrdU, to plasma cells,
which are not proliferating, is shown in Fig. 3. This second
series of experiments also shows the early loss of plasma
cells. After immunization of CGG-primed mice with NP-
CGG, CGG-specific cell numbers peak on day 4, when
most of the cells have come out of cell cycle. Plasma cell
numbers fall between days 5 and 6.5 and thereafter remain
constant through day 10. The kinetics of the NP-specific
cells is similar, the only difference being a delay of up to 24 h
in the time peak numbers are reached and plasmablasts
come out of cell cycle. The proportions of NP-specific
cells and CGG-specific cells lost between days 5 and 6.5 are
roughly equal (Fig. 3), indicating that a similar proportion
of the plasma cells generated from memory B cells as well
as those generated from virgin B cells dies early.
 
Plasmablast Growth and Plasma Cell Survival When Large
Numbers of B Cells Are Recruited into the Extrafollicular Re-
sponse.
 
High level recruitment of NP-specific cells into
the extrafollicular response was achieved in QM mice im-
Figure 2. The distribution of plasma cells
during the responses to NP-CGG in CGG-
primed normal mice (a–c) and to NP-Ficoll
in QM mice in which some 60% of the B
cells have high affinity receptors for NP (d–
f). The color that identifies molecules in
each section is shown at the top right of
each panel. (a and b) Sections showing ex-
trafollicular foci (J) at the junction of the red
pulp (R) and T zone (T) 4 d after NP-CGG
challenge. G, germinal center; F, follicular
mantle. Most of the plasma cells in the focus
are CGG specific (b). (c and f) The typical
dispersed pattern of plasma cells in the red
pulp late in antibody responses, showing (f)
a junction zone with CD11chigh dendritic
cells now largely free of NP-specific plasma
cells. (d) NP-specific plasmablasts filling the
red pulp of QM mice 3 d after immuniza-
tion with NP-Ficoll. (e) A QM mouse 3 d
later in the response when most of the NP-
specific antibody-forming cells have died,
with a cluster of residual plasma cells in a
junction zone (J).
Figure 3. The peak number, proliferation, and decline of red pulp an-
tigen-specific antibody-containing cells in mice primed with CGG and
reimmunized with NP-CGG. (a) The total number of CGG-binding
plasmablasts and plasma cells/mm2 of red pulp in individual mice (r and
n, respectively); medians are joined by a solid line. The number of
CGG-binding cells that had taken up BrdU in the 2 h before the spleen
was taken are shown (u); medians are joined by a dashed line (the BrdU
labeling data were obtained from the mice whose total CGG-specific an-
tibody-containing cell counts are shown [n]). (b) Equivalent results for
NP-binding plasmablasts and plasma cells in the same mice studied in
panel a. Numbers on x-axis in italics indicate observations with values be-
low the scale. 
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munized with NP-Ficoll; some 60% of QM B cells have
high affinity for NP (14).
The frequency of responding B cells is far greater than in
the response to NP-CGG in CGG-primed mice. Never-
theless, the extent of extrafollicular growth per cell re-
cruited into the two responses is similar; the cells in both go
through five cell cycles (Fig. 1). The plasmablasts in the
QM response to NP-Ficoll completely fill the red pulp of
the spleen after 3 d (Fig. 2 d), when the peak number of
antigen-specific cells is reached. There is massive loss of plasma
cells in this response until a plateau is reached by 6 d. The
number of residual plasma cells is in the same range as
that seen in the later stages of the other two responses
where peak numbers of plasmablasts produced are, respec-
tively, some one and two orders of magnitude lower (Fig.
1). Some of the residual plasma cells after 6 d in the QM re-
sponse were distributed in clusters in the junction zone, but
others were scattered in the red pulp (Fig. 2 e). As in the
other responses, by the third week after immunization the
residual plasma cells were mainly in the red pulp (Fig. 2 f).
Despite great differences in the number of B cells re-
cruited into the three responses studied, the extent of plas-
mablast growth appears similar in all three responses. This
result makes it unlikely that the growth of plasmablasts is
controlled by stromal capacity to sustain growth. The re-
sults are more consistent with the growth being regulated
within the cell, i.e., the trigger that induces B cells to pro-
liferate and differentiate into plasmablasts sets a program for
a finite number of cell divisions after which the cells come
out of cell cycle and differentiate into plasma cells.
 
Persistent Plasma Cells in Splenic Antibody Responses Are
Associated with Prolonged Survival Rather Than a Low Rate of
Renewal of Short-lived Plasma Cells.
 
BrdU pulse–chase ex-
periments were carried out to probe whether splenic
plasma cells found late in antibody responses originate from
plasmablast growth outside follicles or from germinal cen-
ters. The approach takes advantage of differences in the
times when follicular and extrafollicular plasma cell precur-
sors proliferate. Extrafollicular growth induced by NP-
CGG in carrier-primed mice stops on the fourth day after
immunization (Fig. 3). The main proliferative burst of plas-
mablasts in QM mice immunized with NP-Ficoll stops at
the same stage of the response. Thus, BrdU given in drink-
ing water between 72 and 96 h after the challenge would
be expected to label most plasma cells formed in extrafolli-
cular foci. Cells in germinal centers continue to proliferate
after this time and rapidly dilute any BrdU taken up; this
falls to levels undetectable by immunohistology within
three cell divisions (24).
Two experiments were carried out in CGG-primed
mice after challenge with NP-CGG: (a) with BrdU given
from 60 to 96 h after immunization when the proportions
of labeled antigen-specific cells on days 5 and 18 were
compared (
 
s
 
, Fig. 4, a–d); and (b) with BrdU from 72 to
96 h and analysis at days 5, 6.5, and 9 (
 
d
 
, Fig. 4, a–d).
There is a major loss of plasma cells between days 5 and
6.5, with relatively little further loss in the following 12 d.
Many plasma cells labeled by the BrdU pulse survived the
early period of apoptosis. It seems likely that most of the
BrdU-labeled plasma cells found on day 18 were derived
from plasmablasts growing in extrafollicular foci during the
BrdU pulse, although it is also possible that some of these
were early emigrants from germinal centers. It may be sig-
nificant that the number of CGG-specific plasma cells fell
more than the number of NP-specific cells and that the
proportion of BrdU-labeled CGG-specific plasma cells re-
mained higher. These findings might relate to the domi-
nance of NP-specific germinal centers in the response of
CGG-primed mice to NP-CGG (4), i.e., a high proportion
of the plasma cells coming from germinal centers in this re-
sponse are likely to be NP specific.
Figure 4. The number of antibody-containing cells and the proportion
labeled by a BrdU pulse given from 60 to 96 h (s) or from 72 to 96 h
(d) after CGG-primed mice had been immunized with NP-CGG, or for
the first 4 d of the response of QM mice to NP-Ficoll (r). (a) The total
number of CGG-binding cells in the red pulp at intervals after immuniza-
tion. (b) The percentage of the CGG-binding cells that were BrdU la-
beled. (c and d) The equivalent results obtained in the same mice for NP-
binding red pulp cells. (e and f) The results for QM mice immunized with
NP-Ficoll. *Unimmunized QM mice were given BrdU 14–10 d before
the spleen was taken to assess the equivalent turnover of the significant
background number of NP-specific plasma cells in the spleens of these
mice. Each point shows data from one mouse. Number of cells is ex-
pressed as the number/mm2 of red pulp assessed in tissue sections. 
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Further BrdU pulse–chase experiments were carried out
in QM mice in the response to NP-Ficoll. In these studies,
BrdU was given in the drinking water during the first 4 d
after giving NP-Ficoll, and the number and proportion of
labeled NP-specific plasma cells were assessed at the end of
the 4-d pulse and 10 d later (Fig. 4, e and f). As in the NP-
CGG response, a substantial proportion of the plasma cells
in the red pulp 14 d after immunization was labeled by the
BrdU given in the first 4 d of the response.
In complete contrast to the control of plasmablast
growth, the persistence of splenic plasma cells follows a
pattern consistent with the spleen having a finite capacity
to support plasma cell survival. Those plasma cells that sur-
vive 
 
.
 
3 d are located mainly in the junction zones be-
tween the T zone and red pulp. At this stage, the surviving
cells show a close association with the CD11c
 
high
 
 dendritic
cells that are located in the junction zones (24). After a few
days, the plasma cells become more dispersed in the red
pulp, leaving the junction zone with its CD11c
 
high
 
 den-
dritic cells relatively free of plasma cells (Fig. 2 f).
 
Splenic Plasma Cells Derived from Follicles Are Not Simply
Migrants on Their Way from Follicles to the Bone Marrow.
 
To label plasma cells emerging from germinal centers se-
lectively, further BrdU pulse labeling experiments were
performed in which BrdU was given in the drinking water
between days 14 and 18. This is already 10 d after the end
of extrafollicular growth, but the mainly NP-specific ger-
minal centers are still active at this time. After this late
pulse, 5% of CGG-specific plasma cells were labeled on day
18 and, surprisingly, the median number of labeled plasma
cells at that time and 10 d later was similar (0.85 vs. 0.66
cells/mm
 
2
 
; Table I). As in the previous experiments, there
were fewer NP-specific plasma cells on day 18, but 
 
z
 
15%
of these were labeled with BrdU. A higher proportion
(80%) of these cells had been lost 10 d later (1.23 vs. 0.28
cells/mm
 
2
 
). These data may reflect slow replacement of
splenic plasma cells late in antibody responses from the pre-
dominantly NP-specific germinal centers present. Only a
 
small proportion of the splenic plasma cells at 18 d appears
to be migrants on the way to the bone marrow.
 
A Small Proportion of NP-specific Red Pulp Plasma Cells
Generated in the Response to NP-CGG in Carrier-primed Mice
Has Mutations in the Ig V Region Genes.
 
The experiments
in the previous section indicate that a substantial minority
of plasma cells found in the red pulp is long-lived. Some of
these appear to arise from B cells growing in extrafollicular
foci, whereas others are later emigrants from follicles. To
investigate this further, the sequences of IgH V region
genes from single NP-specific red pulp plasma cells were
determined at 5 and 18 d after CGG-primed mice had
been challenged with NP-CGG. The genomic DNA was
amplified using primers designed to bind to members of
the V186.2 and V3 V-segment families. Sequences were
obtained from 33 individual NP-specific plasma cells
picked from day 5 tissue sections. Seven of these contained
V region mutations; five had five or more mutations in
their V region (Table II, and Fig. 5 a). Among the 33 se-
quences derived on day 5, sequences 5b-25 and 5b-26
(Fig. 5 a) were identical and mutated. The V region se-
quences, 5b-9 and 5b-10, obtained from two further cells
taken from the same day 5 spleen section (Fig. 5 a) were
identical, but had no mutations. Germinal centers reach
peak size on the fourth day after immunization in this re-
sponse, and memory cells are clearly identifiable in the
marginal zones from day 4 onwards (2, 4); it seems likely
that the NP-specific plasma cells with mutated V region
sequences found in the red pulp at 5 d are early emigrants
from germinal centers.
A further 53 sequences from NP-specific red pulp
plasma cells were obtained at day 18. 12 of these had V re-
gion gene mutations (Table II, and Fig. 5 b). All of the 53
sequences derived from NP-specific plasma cells on day 18
were from different clones, as judged by CDR3 diversity.
Both the day 5 and day 18 sequences show evidence of an-
tigen-driven selection; the numbers of silent and replace-
ment mutations in framework sequences were comparable,
 
Table I.
 
A Proportion of Red Pulp Plasma Cells Is Produced in Germinal Centers and Persists in the Red Pulp for 
 
.
 
10 d
 
Mouse no.
CGG-specific
cells/mm
 
2
 
BrdU
 
1
 
 CGG-specific
cells/mm
 
2
 
NP-specific
cells/mm
 
2
 
BrdU
 
1
 
 NP-specific
cells/mm
 
2
 
Day 18 Day 28 Day 18 Day 28 Day 18 Day 28 Day 18 Day 28 Day 18 Day 28
1 5 16.6 6.7 0.75 0.66 7.9 4.3 1.32 0.18
2
 
*
 
6 0.6
 
*
 
7.0 0.12
 
*
 
0.53 9.5 5.9 1.52 0.41
3 7 20.2 12.8 0.95 1.01 8.5 4.0 1.33 0.28
4 8 14.4 14.8 0.95 0.87 7.2 3.6 1.14 0.15
9 10.6 0.44 5.4 0.51
 
Median 15.5 10.6 0.85 0.66 8.2 4.3 1.23 0.28
 
Mice primed with CGG were reimmunized with NP-CGG and given a BrdU pulse 14–18 d later; at this time, B cell growth in the spleen is confined
to germinal centers. The total number and number of BrdU
 
1
 
 antigen-specific plasma cells in the red pulp were determined on day 18 and day 28
after the NP-CGG boost.
 
*
 
Mouse no. 2 had an atypically low anti-CGG antibody response. 
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whereas replacements were markedly greater than silent
mutations in CDR1 and 2 (Table II).
The canonical V186.2 V segment associated with NP-
specific cells in the response to NP-CGG in IgH
 
b
 
 mice was
used by 38% of the NP-specific plasma cells picked from
 
day 5 sections and 26% of those taken at day 18. Only 1 of
these V186.2-containing regions had the classical position
33 mutation from tryptophan to leucine, which increases
the affinity of anti-NP antibodies using this V segment
 
z
 
10-fold (25). The broad range of anti-NP sequences seen
in these mice, which were carrier-primed before immuniz-
ing with NP-CGG, is a feature of carrier priming; it is
quite unlike the more restricted range of V regions seen in
a primary response to NP-CGG (2, 11, 12). This effect of
carrier priming has been analyzed in detail and will be re-
ported elsewhere.
These sequencing studies reinforce the conclusions
drawn from the BrdU pulse–chase studies that long-lived
plasma cells in the spleen are derived partially from germi-
nal centers, but that many are derived from plasmablast
growth in extrafollicular foci, as the majority lacks Ig V re-
gion gene mutations.
 
Ig Class Switching Does Not Appear to Influence Which
Splenic Plasma Cells Become Long-lived.
 
Sections from the
pulse–chase experiment described above, in which BrdU
was given during extrafollicular plasmablast growth, were
triple-stained to identify the NP-specific plasma cells.
These indicate: (a) whether these cells had taken up BrdU
during the fourth day after immunization, and (b) whether
Table II. V Segment Use and the Frequency of Framework versus 
CDR Mutations in NP-specific Red Pulp Plasma Cells from Mice 
during the Response to NP-CGG in Carrier-primed Mice
5 d after
NP-CGG
18 d after
NP-CGG
Total no. of sequences 33 53
No. of sequences with mutations 7 12
No. of sequences with V186.2 12 14
No. of V186.2 mutated 3 5
No. of V186.2 codon 33 Trp®Leu 0 1
Silent framework mutations 7 13
Replacement framework mutations 6 10
Silent CDR1 and 2 mutations 2 5
Replacement CDR1 and 2 mutations 16 22
Figure 5. Individual Ig V re-
gion DNA sequences obtained
from (a) 33 and (b) 53 single
NP-binding red pulp plasma
cells from sections of spleen
taken (a) 5 and (b) 18 d after
CGG-primed mice had been re-
immunized with NP-CGG. The
sequences are assigned to indi-
vidual V segment families, and
any mutations from the germline
sequence are indicated; only
those codons that differ from the
reference sequences are shown.
The sequences are set out in two
broad Ig V segment families, V3
and V186.2. Lowercase letters
indicate silent mutations, upper-
case characters replacement mu-
tations; dashes indicate identity
with the reference sequence.
FR, framework region of the V
segment. The sequence data
summarized in this figure are
available from EMBL/Gen-
Bank/DDBJ under accession
nos. AJ240347–AJ240379 (a)
and AJ240293–AJ240346 (b).
Sequences V303 and V304 are
likely to be new germline V seg-
ment genes, as they have been
found after immunization with a
TI-2 antigen by others (EMBL/
GenBank/DDBJ accession no.
AF 045500), and we have found
them repeatedly in responses to
NP-Ficoll.820 Constraints on Plasmablast Growth and Plasma Cell Survival
they had switched to produce IgG. The results are shown
in Table III. They show no obvious influence of switch
recombination on the life span of splenic plasma cells.
Concluding Discussion. Why are so many splenic plasma
cells formed in extrafollicular foci lost within 3 d? The find-
ings of this study argue against preordained early death
among a subset of plasma cells; rather, it appears that a ran-
dom proportion of all plasma cells dies. It has been suggested
that CD11chigh dendritic cells found in extrafollicular foci of
plasmablast growth play a role in plasmablast differentiation
and their subsequent survival (5). When plasmablasts out-
grow the number of these dendritic cells, surviving plasma
cells are closely associated with the dendritic cells. Con-
versely, experimental conditions that expand the dendritic
cell stroma have been found to be associated with survival of
an increased number of plasma cells. This association with
dendritic cells ceases to be as strong later in antibody re-
sponses when the plasma cells have mostly left extrafollicular
foci and are scattered throughout the red pulp. This move of
the plasma cells clears extrafollicular foci for further antibody
responses. The signals or nutrients that sustain plasma cell
survival in foci and the broader red pulp are still unknown.
The data obtained in this study are consistent with the
following conclusions: (a) red pulp plasmablasts go through
some five cycles of exponential growth over 3 d before
coming out of cell cycle as plasma cells, or entering apopto-
sis; (b) mouse spleen can support the continued survival of
a finite number of antibody-secreting cells (in the mice in-
vestigated, this is z20–100 cells/mm2 of red pulp; (c) when
plasmablasts and plasma cell numbers exceed this capacity,
the excess cells die after 2–3 d; and (d) after a few days,
plasma cells leave the site of extrafollicular growth and be-
come more scattered in the red pulp.
Extrafollicular plasmablast growth provides the first anti-
body produced after exposure to antigen; B cells differenti-
ate into plasmablasts z1 d after cognate interaction with T
cells (4, 19), or activation by a T cell–independent antigen
(5). This early production can be critical in the control of
virus spread or neutralization of bacterial toxins. Antibody-
producing cells do not leave germinal centers for a further
2–3 d (11, 12). The later response in germinal centers can
improve the quality of the antibody (11, 12), although in
certain infections there are sufficient high affinity virgin B
cells to produce efficient neutralizing antibody in the ex-
trafollicular response (26).
The scenario in which plasmablasts growth overshoots
the capacity of stroma to sustain long-term plasma cell sur-
vival fulfills the requirement for early protective antibody
production. At the same time, a lower level of sustained
splenic antibody production protects where there is no fol-
licular response—as for example in responses to some bac-
terial capsular polysaccharides.
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Table III. Lack of Correlation between the Class of Antibody Produced by Red Pulp Plasma Cells and Their Life Span
Spleen code/
day assessed
CGG-specific
IgG1 cells
CGG-specific
IgG2 cells
NP-specific
IgG1 cells
NP-specific
IgG2 cells
n/mm2 % BrdU1 n/mm2 % BrdU1 n/mm2 % BrdU1 n/mm2 % BrdU1
A/day 5 134 57 40 30 20 50 30 23
B/day 5 79 63 9 30 15 31 17 29
C/day 5 69 56 10 23 11 55 45 40
D/day 5 72 63 10 17 8 32 27 77
Median/day 5 76 63 10 27 13 32 29 35
E/day 6.5 20 38 2 20 4 31 3 13
F/day 6.5 71 50 10 33 12 6 6 37
G/day 6.5 9 38 2 21 2 25 2 17
Median/day 6.5 20 38 2 21 4 25 3 17
H/day 9 51 62 12 37 7 10 7 20
I/day 9 29 45 4 23 17 22 8 19
J/day 9 13 43 36593 1 6
K/day 9 23 28 4 23 6 27 8 23
Median/day 9 26 44 4 23 7 16 8 20
The mice shown in this table were primed with CGG and boosted with NP-CGG. They were given a BrdU pulse between 72 and 96 h after
immunization; the number of antigen-specific plasma cells and the proportions of these that had taken up BrdU during the pulse were assessed on
the day after immunization indicated in the leftmost column.821 Sze et al.
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